Literature DB >> 10417738

Understanding the genetic basis of susceptibility to mycobacterial infection.

M Levin1, M Newport.   

Abstract

Genetic factors have long been suspected of determining susceptibility and resistance to mycobacterial infection. The recent identification of families with a unique susceptibility to mycobacterial infection, and the identification of mutations in the genes for either the interferon-gamma (IFN-gamma) receptor or the interleukin (IL)-12 receptor as the cause of the defect, has provided an important clue to the pathways critical for resistance to mycobacterial infection in humans. Although the genetically determined absence of key cytokines or their receptors results in susceptibility to lethal mycobacterial infections in early childhood, it is likely that more subtle mutations that result in only partial dysfunction of macrophage upregulation pathways may play a role in susceptibility to tuberculosis (TB) and leprosy in the general population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417738     DOI: 10.1046/j.1525-1381.1999.99242.x

Source DB:  PubMed          Journal:  Proc Assoc Am Physicians        ISSN: 1081-650X


  8 in total

1.  Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages.

Authors:  Hyosun Cho; David N McMurray
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts.

Authors:  Guido Silvestri; Andrew Fedanov; Stephanie Germon; Natalia Kozyr; William J Kaiser; David A Garber; Harold McClure; Mark B Feinberg; Silvija I Staprans
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 3.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

Review 4.  Paediatric tuberculosis.

Authors:  Sandra M Newton; Andrew J Brent; Suzanne Anderson; Elizabeth Whittaker; Beate Kampmann
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

5.  Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.

Authors:  Beate Kampmann; Cheryl Hemingway; Alick Stephens; Robert Davidson; Anna Goodsall; Suzanne Anderson; Mark Nicol; Elisabeth Schölvinck; David Relman; Simon Waddell; Paul Langford; Brian Sheehan; Lynn Semple; Katalin A Wilkinson; Robert J Wilkinson; Stanley Ress; Martin Hibberd; Michael Levin
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

6.  Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.

Authors:  Roberto Suárez-Méndez; Idrian García-García; Norma Fernández-Olivera; Magalys Valdés-Quintana; María T Milanés-Virelles; Dalia Carbonell; Delfina Machado-Molina; Carmen M Valenzuela-Silva; Pedro A López-Saura
Journal:  BMC Infect Dis       Date:  2004-10-22       Impact factor: 3.090

7.  Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis.

Authors:  Daniel Fisch; Hironori Bando; Barbara Clough; Veit Hornung; Masahiro Yamamoto; Avinash R Shenoy; Eva-Maria Frickel
Journal:  EMBO J       Date:  2019-06-03       Impact factor: 11.598

Review 8.  White blood cell defects: molecular discoveries and clinical management.

Authors:  Gulbu Uzel; Steven M Holland
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.